Silence Therapeutics Investor

Silence Therapeutics is a drug development company with a proprietary genetic medicine platform.
Technology: AgeTech Companies
Industry: Healthcare
Headquarters: London, England, United Kingdom
Founded Date: 1999-01-01
Employees Number: 11-50
Funding Status: IPO
Number Of Exits: 1
Estimated Revenue: Less than $1M

Visit Website
info@silence-therapeutics.com
https://twitter.com/silencetheraplc
Register and Claim Ownership